Mark Rogers‐Evans

Oxetanes in Drug Discovery: Structural and Synthetic Insights

Georg Wuitschik, Erick M. Carreira, Björn Wagner et al. · Journal of Medicinal Chemistry · 2010 · 402 citations

Medicinal Chemistry, Heterocyclic, Biochemistry +10

Oxetanes as Promising Modules in Drug Discovery

Georg Wuitschik, Mark Rogers‐Evans, Klaus Müller et al. · Angewandte Chemie International Edition · 2006 · 255 citations

Drug Target, Bioorganic Chemistry, Organic Chemistry +17

Development of a Virtual Screening Method for Identification of “Frequent Hitters” in Compound Libraries

Olivier Roche, Petra Schneider, Jochen Zuegge et al. · Journal of Medicinal Chemistry · 2001 · 250 citations

Engineering, Hit Identification, Pattern Discovery +24

Spirocyclic Oxetanes: Synthesis and Properties

Georg Wuitschik, Mark Rogers‐Evans, A. Buckl et al. · Angewandte Chemie International Edition · 2008 · 221 citations · Full text

β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease

Hans Hilpert, Wolfgang Guba, Thomas J. Woltering et al. · Journal of Medicinal Chemistry · 2013 · 136 citations · Full text

Neurochemical Biomarkers, Pharmacotherapy, Alzheimer ’ +24